The University of Chicago Header Logo

Connection

Erika C. Claud to NF-kappa B

This is a "connection" page, showing publications Erika C. Claud has written about NF-kappa B.
Connection Strength

0.867
  1. Oral administration of transforming growth factor-ß1 (TGF-ß1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor ?B (NF-?B) signaling and proinflammatory cytokine production. J Biol Chem. 2013 Nov 29; 288(48):34757-66.
    View in: PubMed
    Score: 0.353
  2. Developmentally regulated tumor necrosis factor-alpha induced nuclear factor-kappaB activation in intestinal epithelium. Am J Physiol Gastrointest Liver Physiol. 2007 May; 292(5):G1411-9.
    View in: PubMed
    Score: 0.223
  3. Transcriptional modulation of intestinal innate defense/inflammation genes by preterm infant microbiota in a humanized gnotobiotic mouse model. PLoS One. 2015; 10(4):e0124504.
    View in: PubMed
    Score: 0.098
  4. Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury. PLoS One. 2013; 8(5):e65108.
    View in: PubMed
    Score: 0.086
  5. Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis. 2009 Oct; 15(10):1537-47.
    View in: PubMed
    Score: 0.067
  6. Administration of defined microbiota is protective in a murine Salmonella infection model. Sci Rep. 2015 Nov 04; 5:16094.
    View in: PubMed
    Score: 0.025
  7. Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol. 2007 Sep; 171(3):882-92.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.